Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Axlab AB
AB
Active
Org 5590158100
S:T Johannesgatan 2, 211 46
Malmö
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2015 · 11 years old
5 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Axlab AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
16M
12M
8M
4M
0M
2021: 5M
5M
2021
2022: 4M (-20% vs 2021)
4M
-20%
2022
2023: 5M (+25% vs 2022)
5M
+25%
2023
2024: 9M (+80% vs 2023)
9M
+80%
2024
2025: 13M (+44% vs 2024)
13M
+44%
2025
EBITDA
SEK millions
2M
1M
-1M
-3M
-4M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: -3M (-400% vs 2022)
-3M
-400%
2023
2024: 1M (+133% vs 2023)
1M
+133%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
12 879
9 430
5 271
4 119
4 688
Staff expenses
—
—
—
—
—
EBITDA
708
602
−2 506
513
1 054
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
708
602
−2 506
513
1 054
Net financials
−63
−105
−187
−97
−39
Profit before tax
644
496
−2 692
416
1 015
Tax
−0
−0
−0
−86
−209
Net profit
644
496
−2 692
330
806
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
4 910
4 875
4 616
2 671
2 126
Equity
1 190
546
50
2 153
1 822
Long-term debt
0
0
0
0
0
Short-term debt
3 719
4 330
4 566
518
303
Total debt
3 719
4 330
4 566
518
303
Financial ratios
5-year trend
EBITDA margin
5,5 %
This company
15,8 %
Market median
This company
Market median
65% below market
2021
2025
Equity ratio
24,2 %
This company
38,2 %
Market median
This company
Market median
37% below market
2021
2025
Return on equity
54,1 %
This company
18,4 %
Market median
This company
Market median
194% above market
2021
2025
Net profit margin
5,0 %
This company
8,1 %
Market median
This company
Market median
38% below market
2021
2025
Asset turnover
2,62×
This company
1,12×
Market median
This company
Market median
134% above market
2021
2025
Debt / equity
3,13×
This company
0,62×
Market median
This company
Market median
405% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Axlab AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
